Other Species / Isoforms
  Siglec-10 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S8-p
MLLPLLLssLLGGSQ
0 1
Siglec-10 (human) MLLPLLLssLLGGSQ S8-p
Siglec-10 iso2 (human) MLLPLLLSSLLGGSQ S8
Siglec-10 (mouse) SLLLFLLSFLLDGPQ S9
S9-p
LLPLLLssLLGGSQA
0 1
Siglec-10 (human) LLPLLLssLLGGSQA S9-p
Siglec-10 iso2 (human) LLPLLLSSLLGGSQA S9
Siglec-10 (mouse) LLLFLLSFLLDGPQG F10
S38-p
VPEGLCIsVPCSFSY
0 1
Siglec-10 (human) VPEGLCIsVPCSFSY S38-p
Siglec-10 iso2 (human) VPEGLCISVPCSFSY S38
Siglec-10 (mouse) AQEGLCIFVPCSFSS F39
Y57-p
WTGSTPAyGYWFKAV
0 1
Siglec-10 (human) WTGSTPAyGYWFKAV Y57-p
Siglec-10 iso2 (human) WTGSTPAYGYWFKAV Y57
Siglec-10 (mouse) WLNRSPLYGYWFKGI Y58
T250-p
ISISRDNtPALEPQP
0 1
Siglec-10 (human) ISISRDNtPALEPQP T250-p
Siglec-10 iso2 (human) ISISRDNTPALEPQP T250
Siglec-10 (mouse) ISIFHDNVSVPDLHE V247
T322-p
AGDSGRYtCRAENRL
0 1
Siglec-10 (human) AGDSGRYtCRAENRL T322-p
Siglec-10 iso2 (human) AGDSGRYTCRAENRL T322
Siglec-10 (mouse) AGDSGHYTCQAENRL T317
S331-p
RAENRLGsQQRALDL
0 1
Siglec-10 (human) RAENRLGsQQRALDL S331-p
Siglec-10 iso2 (human) RAENRLGSQQRALDL S331
Siglec-10 (mouse) QAENRLGSQQHTLDL S326
S339-p
QQRALDLsVQYPPEN
0 1
Siglec-10 (human) QQRALDLsVQYPPEN S339-p
Siglec-10 iso2 (human) QQRALDLSVQYPPEN S339
Siglec-10 (mouse) QQHTLDLSVLYPPQD S334
V398
SWTQRGQVLSPSQPS
0 1
Siglec-10 (human) SWTQRGQVLSPSQPS V398
Siglec-10 iso2 (human) SWTQRGQVLSPSQPS V398
Siglec-10 (mouse) SWAWVTQtLIPIQSS T393-p
S589-p
ETPRPRFsRHstILD
0 1
Siglec-10 (human) ETPRPRFsRHstILD S589-p
Siglec-10 iso2 (human) ETPRPRFSRHSTILD S494
Siglec-10 (mouse) EPSRPKLSRGSTILD S582
S592-p
RPRFsRHstILDyIN
0 1
Siglec-10 (human) RPRFsRHstILDyIN S592-p
Siglec-10 iso2 (human) RPRFSRHSTILDYIN S497
Siglec-10 (mouse) RPKLSRGSTILDyIN S585
T593-p
PRFsRHstILDyINV
0 4
Siglec-10 (human) PRFsRHstILDyINV T593-p
Siglec-10 iso2 (human) PRFSRHSTILDYINV T498
Siglec-10 (mouse) PKLSRGSTILDyINV T586
Y597-p
RHstILDyINVVPTA
Upstream
1 7
Kinase, in vitro:
  • ITK (human)
  • JAK3 (human)
  • Lck (human)
Siglec-10 (human) RHstILDyINVVPTA Y597-p
Siglec-10 iso2 (human) RHSTILDYINVVPTA Y502
Siglec-10 (mouse) RGSTILDyINVVPKT Y590-p
S630-p
PLPPGAPsPESKKNQ
0 2
Siglec-10 (human) PLPPGAPsPESKKNQ S630-p
Siglec-10 iso2 (human) PLPPGAPSPESKKNQ S535
Siglec-10 (mouse) SSPLDTHFPKPKKKQ F621
S645-p
KKQYQLPsFPEPKSS
0 1
Siglec-10 (human) KKQYQLPsFPEPKSS S645-p
Siglec-10 iso2 (human) KKQYQLPSFPEPKSS S550
Siglec-10 (mouse) DPHFTYPGCPDPTSS G637
Y667-p
ESQEELHyATLNFPG
Upstream
Downstream
2 2
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • ITK (human)
  • JAK3 (human)
  • Lck (human)
Putative in vivo kinases:
  • Fyn (human)
Siglec-10 (human) ESQEELHyATLNFPG Y667-p
Siglec-10 iso2 (human) ESQEELHYATLNFPG Y572
Siglec-10 (mouse) NNPEELHYAALNFSR Y659
Y691-p
PKGTQADyAEVKFQ_
Upstream
1 10
Kinase, in vitro:
  • JAK3 (human)
  • Lck (human)
Siglec-10 (human) PKGTQADyAEVKFQ_ Y691-p
Siglec-10 iso2 (human) PKGTQADYAEVKFQ_ Y596
Siglec-10 (mouse) PQDTYSDYTEVRVH_ Y682